medication management
ApprovedSmall molecule
medication management is one of 118 small molecule programs targeting Cocaine Dependence. It is currently in Approved.
3
Indications
4
Total Trials
1
Active Trials
117
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
687 competitors in Heart Failure
#DrugCompanyPhaseTrials
1medication management
UUniversity of Pennsylvania
Approved
Bayer Aspirin
BayerPreclinical
Medrol
PfizerPreclinical
Brethine
SanofiPreclinical
Amidate
PfizerPreclinical
LCZ696
NovartisPreclinical
Monoferric
PPharmacosmos A/S
Preclinical
Zemplar
AbbViePreclinical
Bystolic
VVitae Pharmaceuticals Inc., an Allergan affiliate
Preclinical
Activase
RochePreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Opioid Use Disorder1 trial
Dynamic Treatment Regimes for Opioid Use Disorder
Not yet recruiting·—·Phase 2·NCT07011758·75 enrolled
Heart Failure1 trial
Personalized Treatments for Depressive Symptoms in Patients With Advanced Heart Failure
Completed·—·Phase 4·NCT03688100·494 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for medication management. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Approved[1]
- Company
- UUniversity of Pennsylvania